Form 4: cbdMD Director Kevin Roe Reports Acquisition and Disposal of Common Stock

Director Kevin Roe reports acquiring 1,572 shares of cbdMD, Inc. common stock and disposing of 0 shares on May 16, 2025, according to a Form 4 filing.

Summary

• On May 16, 2025, Kevin Roe, a director of cbdMD, Inc. (YCBD), reported acquiring 1,572 shares of common stock.
• The acquisition was in the form of restricted stock units, each representing a contingent right to receive one share of the Issuer's common stock.
• The price of the acquired shares was $0.
• Following the transaction, Roe beneficially owns 25,135 shares of common stock.
• The restricted stock units vest quarterly on June 30, 2025, September 30, 2025, December 31, 2025 and March 31, 2026.
• The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors.
• The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by a company director. The acquisition of shares could be interpreted as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers. These filings are closely watched by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, Kevin Roe, cbdMD, YCBD, Restricted Stock Units, Equity Compensation